News
Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...
The ruling, seen as a major victory for transparency campaigners, piles pressure on Ursula von der Leyen over the opaque nature of the EU's vaccine negotiations during the pandemic.
A top European court says the European Commission was wrong to refuse the New York Times access to text messages sent between President Ursula von der Leyen and a pharmaceutical boss during the COVID- ...
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
Following President Trump’s announcement on Monday of an executive order to cut prescription drug prices, experts share some of the most expensive medications.
Health-care companies rose sharply after President Trump signed an executive order designed to lower what Americans pay for prescription drugs that offered pharmaceutical companies room for ...
But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...
The banning of pharmaceutical advertisements is not an assault on free speech. Big Pharma cannot be trusted with the health of Americans.
We recently published a list of Jim Cramer Reveals Trump’s Potential Secret Weapon In China Trade Talks & Discusses These 10 Stocks. In this article, we are going to take a look at where Pfizer Inc.
The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results